Tag:
Advagraf
Latest Headlines
Latest Headlines
UPDATED: Astellas gets EMA OK for precautionary Advagraf recall*
The European Medicines Agency has given its OK for a precautionary recall of Astellas Pharma's ( $ALPMY ) Advagraf 0.5-mg capsules, citing the presence of more API than is standard. The 12-batch recall
Astellas faces new delay for Advagraf approval
Japan's Astellas Pharma has run into a new roadblock in its pursuit of regulatory approval of Advagraf, its second generation version of the blockbuster transplant drug Prograf. The FDA has raised
